info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)
Certified Global Research Member
Esomar23 wcrc
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Lancet Pen Needles Market Share

ID: MRFR//0112-CR | 145 Pages | Author: Kinjoll Dey| July 2019

Lancet Pen Needles Market Share Analysis

In recent years, there has been a notable surge in the popularity of Point-of-Care Testing (POCT) devices, particularly among diabetic patients. This inclination can be attributed to the reduced turnaround time required for glucose level checks, resulting in improved patient care. A study featured in Oxford Journals revealed a significant contrast in turnaround times between central laboratories and POCT devices. While central laboratories took approximately 90 minutes to provide glucose results, POCT devices, on average, delivered results in just 5 minutes. The swift results, coupled with the ease of handling and enhanced accuracy, are key drivers fueling the growing utilization of home healthcare diagnostics kits.
Lancets, a vital component in home healthcare diagnostics, play a crucial role in monitoring diabetes within the diabetic population. According to the World Health Organization (WHO), in 2014, 8.5% of adults aged 18 years and older were reported to have diabetes. Moreover, diabetes emerged as the direct cause of 1.5 million deaths in 2012, with an additional 2.2 million deaths attributed to high blood glucose levels.

Considering the current trajectory of diabetes prevalence, if these trends persist, the diabetic patient population is expected to witness a substantial increase over the next decade. The escalating prevalence of diabetes underscores the anticipated tremendous demand for lancets. This surge in demand for lancets aligns with the broader trend of increased demand for devices and products aimed at monitoring and controlling diabetes. Consequently, the heightened consumption of lancets becomes a consequential outcome of the growing imperative to manage diabetes effectively.

The multifaceted benefits of POCT devices, including their rapid turnaround times, align seamlessly with the urgent need for timely and efficient monitoring of glucose levels, especially in the diabetic population. The convenience and speed offered by these devices make them an attractive choice for individuals seeking swift and accurate results in the comfort of their homes. As a result, the adoption of POCT devices, along with the indispensable role of lancets in glucose monitoring, contributes significantly to the evolving landscape of home healthcare diagnostics.

The rise in demand for home healthcare diagnostics kits, driven by the popularity of POCT devices, reflects the growing emphasis on efficient and timely healthcare interventions. Lancets, as integral components in glucose monitoring for diabetes, are poised to experience increased demand due to the anticipated surge in the diabetic patient population. This trend aligns with the broader global efforts to enhance diabetes management, emphasizing the pivotal role of diagnostics and monitoring devices in improving patient outcomes.



Covered Aspects:
Report Attribute/Metric Details
Base Year For Estimation   2021
Historical Data 2020
Forecast Period   2022-2030
Growth Rate  10.20%
Leading companies partner with us for data-driven Insights
clients
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.